Neurones S.A.

EPA:NRO.PA

47.8 (EUR) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Revenue 810.4741.175665.379579.879524.489510.074490.075485.014446.76399.368355.17343.165315.402283.311239.568216.39189.328155.977129.967108.9297.09892.73292.623
Cost of Revenue 304.175394.419583.744323.302296.194293.541292.092298.925281.488257.254235.751224.559211.467191.2454.7818.2879.1378.9457.0097.7796.6627.73910.746
Gross Profit 506.225346.75681.635256.577228.295216.533197.983186.089165.272142.114119.419118.606103.93592.071184.787208.103180.191147.032122.958101.14190.43684.99381.877
Gross Profit Ratio 0.6250.4680.1230.4420.4350.4250.4040.3840.370.3560.3360.3460.330.3250.7710.9620.9520.9430.9460.9290.9310.9170.884
Reseach & Development Expenses 00000000000000000000000
General & Administrative Expenses 000170.823150.723143.466142.086133.559116.27798.29978.41978.57666.775.29653.20150.08944.01937.18200055.84154.207
Selling & Marketing Expenses 00000000000000-49.00300000000
SG&A 304.242248.581-10.513170.823150.723143.466142.086133.559116.27798.29978.41978.57666.775.2964.19850.08944.01937.182-0.214-0.068055.84154.207
Other Expenses 428.25822.31821.22520.25921.99615.8578.7356.7976.4856.7455.467.1399.160.481156.042138.958117.76196.012113.98392.44282.39521.56417.971
Operating Expenses 732.5270.89910.712287.052260.577246.957152.057141.041122.762105.04483.87985.71575.76365.777160.24189.046161.78133.101113.76992.37482.39577.40572.178
Operating Income 77.975.85772.89361.57351.86353.69145.96244.86542.5137.0735.5432.89128.06526.29424.54719.05618.41113.8388.9758.6998.0417.5889.699
Operating Income Ratio 0.0960.1020.110.1060.0990.1050.0940.0930.0950.0930.10.0960.0890.0930.1020.0880.0970.0890.0690.080.0830.0820.105
Total Other Income Expenses Net 10.24.908-0.0310.1861.70.121.5922.9162.4351.4311.7171.8551.3932.4920.7110.7221.7931.4891.1580.9340.795-0.204-0.395
Income Before Tax 88.180.76572.86261.75953.56353.81147.55447.78144.94538.50137.25734.74629.45828.78625.25819.77820.20415.32710.1339.6338.8367.3849.304
Income Before Tax Ratio 0.1090.1090.110.1070.1020.1050.0970.0990.1010.0960.1050.1010.0930.1020.1050.0910.1070.0980.0780.0880.0910.080.1
Income Tax Expense 24.922.18321.09118.81918.57818.65417.97716.16815.92313.96313.64713.3612.28111.74710.326.9637.2285.3813.5373.3133.1082.8463.679
Net Income 52.549.4144.24337.70630.91830.79925.95927.3125.19921.35820.50518.5714.84914.79914.93812.81512.9769.9466.5965.9275.4234.8585.958
Net Income Ratio 0.0650.0670.0660.0650.0590.060.0530.0560.0560.0530.0580.0540.0470.0520.0620.0590.0690.0640.0510.0540.0560.0520.064
EPS 2.172.031.831.561.281.271.071.131.040.890.860.780.630.630.570.490.520.390.260.260.210.20.25
EPS Diluted 2.162.031.821.561.271.271.071.121.040.880.850.770.620.620.560.480.510.380.260.250.20.190.24
EBITDA 85.92496.62988.71976.23568.78569.30553.70856.48250.45143.20541.4138.38133.27131.91927.90122.26222.72518.89710.68110.79310.05584.39981.355
EBITDA Ratio 0.1060.130.1330.1310.1310.1360.110.1160.1130.1080.1170.1120.1050.1130.1160.1030.120.1210.0820.0990.1040.910.878